New Edge Advisors, LLC Fulgent Genetics, Inc. Transaction History

New Edge Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$29.39 - $36.27 $9,346 - $11,533	-318 Reduced 57.5%	235 $7,000
Q4 2022 Feb 14, 2023	BUY	$29.23 - $40.28 $16,164 - $22,274	553 New	553 $16,000
Q2 2021 Jul 22, 2021	SELL	$66.8 - $100.45 $206,746 - $310,892	-3,095 Closed	0 $0
Q1 2021 Apr 26, 2021	BUY	$59.3 - $183.85 $183,533 - $569,015	3,095 New	3,095 $299,000

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on New Edge Advisors, LLC with notifications on news.